New data from the UK Health Security Agency (UKHSA) on the Omicron variant has shown the booster vaccine provides 70-75% effectiveness in protecting patients from symptomatic Covid.
However, UKHSA Chief Medical Advisor Susan Hopkins warns there is a "much reduced vaccine effectiveness" against symptomatic mild infection after only two vaccines.
Report by Lewisl.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
